The release of study data is a significant event for pharmaceutical companies like Ardelyx. If the data shows positive results, it could boost investor confidence and potentially lead to a rise in the company's stock price. Conversely, if the data is not as promising, it could lead to a decrease in the stock price. However, without specific details on the study results, it's difficult to predict the exact impact on the stock price.